Jill Farnell Lebov

Jill Farnell Lebov

Auto-generated profile, based on publicly available information

Jill Farnell Lebov

Social Statistical and Environmental Sciences Division, RTI International, Research Triangle Park, North Carolina, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in One Health
Verified
Journal Article
Open access
JLJ. Lebov
J. Lebov
KGK. Grieger
K. Grieger
DWD. Womack
D. Womack
DZD. Zaccaro
D. Zaccaro
NWN. Whitehead
N. Whitehead
PMP.D.M. MacDonald
P.D.M. MacDonald
The need for multidisciplinary research to address today's complex health and environmental challenges has never been greater. The One Health (OH) approach to research ensures that human, animal, and environmental health questions are evaluated in an integrated and holistic manner to provide a more comprehensive understanding of the problem and potential solutions than would be possible with siloed approaches. However, the OH approach is complex, and there is limited guidance available for investigators regarding the practical design and implementation of OH research. In this paper we provide a framework to guide researchers through conceptualizing and planning an OH study. We discuss key steps in designing an OH study, including conceptualization of hypotheses and study aims, identification of collaborators for a multi-disciplinary research team, study design options, data sources and collection methods, and analytical methods. We illustrate these concepts through the presentation of a case study of health impacts associated with land application of biosolids. Finally, we discuss opportunities for applying an OH approach to identify solutions to current global health issues, and the need for cross-disciplinary funding sources to foster an OH approach to research.

1 August 2018 in Pediatric Neurology
Verified
Journal Article
Closed access
JLJill F. Lebov
Jill F. Lebov
LBLinda M. Brown
Linda M. Brown
PMPia D.M. MacDonald
Pia D.M. MacDonald
KRKevin Robertson
Kevin Robertson
NBNatalie M. Bowman
Natalie M. Bowman
SBSylvia Becker-Dreps
Sylvia Becker-Dreps

7 August 2019 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
JLJill F. Lebov
Jill F. Lebov
JAJuan F. Arias
Juan F. Arias
ABAngel Balmaseda
Angel Balmaseda
WBWillilam Britt
Willilam Britt
UGUniversity F. Georgia
University F. Georgia
Carmen D ZorrillaCarmen D Zorrilla
Carmen D Zorrilla
Until recently, Zika virus (ZIKV) infections were considered mild and self-limiting. Since 2015, they have been associated with an increase in microcephaly and other birth defects in newborns. While this association has been observed in case reports and epidemiological studies, the nature and extent of the relationship between ZIKV and adverse pregnancy and pediatric health outcomes is not well understood. With the unique opportunity to prospectively explore the full spectrum of issues related to ZIKV exposure during pregnancy, we undertook a multi-country, prospective cohort study to evaluate the association between ZIKV and pregnancy, neonatal, and infant outcomes. At research sites in ZIKV endemic regions of Brazil (4 sites), Colombia, Guatemala, Nicaragua, Puerto Rico (2 sites), and Peru, up to 10,000 pregnant women will be recruited and consented in the first and early second trimesters of pregnancy and then followed through delivery up to 6 weeks post-partum; their infants will be followed until at least 1 year of age. Pregnant women with symptomatic ZIKV infection confirmed by presence of ZIKV RNA and/or IgM for ZIKV will also be enrolled, regardless of gestational age. Participants will be tested monthly for ZIKV infection; additional demographic, physical, laboratory and environmental data will be collected to assess the potential interaction of these variables with ZIKV infection. Delivery outcomes and detailed infant assessments, including physical and neurological outcomes, will be obtained. With the emergence of ZIKV in the Americas and its association with adverse pregnancy outcomes in this region, a much better understanding of the spectrum of clinical outcomes associated with exposure to ZIKV during pregnancy is needed. This cohort study will provide information about maternal, fetal, and infant outcomes related to ZIKV infection, including congenital ZIKV syndrome, and manifestations that are not detectable at birth but may appear during the first year of life. In addition, the flexibility of the study design has provided an opportunity to modify study parameters in real time to provide rigorous research data to answer the most critical questions about the impact of congenital ZIKV exposure. NCT02856984. Registered August 5, 2016. Retrospectively registered.

19 November 2019 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
JLJill F. Lebov
Jill F. Lebov
JAJuan F. Arias
Juan F. Arias
ABAngel Balmaseda
Angel Balmaseda
WBWilliam Britt
William Britt
JCJosé F. Cordero
José F. Cordero
CZCarmen Zorrilla
Carmen Zorrilla
Following publication of the original article [1], the author mentioned that two additional NIH staff were involved in the development of the protocol who did not receive recognition in the Acknowledgments section in their published article.

20 July 2022 in Revista Panamericana de Salud Pública
Verified
Journal Article
Open access
PDF file
JLJill F. Lebov
Jill F. Lebov
SHStephen R. Hooper
Stephen R. Hooper
NPNorma Pugh
Norma Pugh
SBSylvia Becker-Dreps
Sylvia Becker-Dreps
NBNatalie M. Bowman
Natalie M. Bowman
TRTeresa de Jesús Aleman Rivera
Teresa de Jesús Aleman Rivera
Objectives. To describe the presence and persistence of neurological and neuropsychological sequelae among children with acquired Zika virus infection and assess whether those sequelae were more common in children infected with Zika virus compared to uninfected children. Methods. We conducted a prospective cohort study of children with and without Zika virus infection in León, Nicaragua, using a standard clinical assessment tool and questionnaire to collect data on symptoms at three visits, about 6 months apart, and a battery of standardized instruments to evaluate neurocognitive function, behavior, depression, and anxiety at the last two visits. Results. Sixty-two children were enrolled, with no significant differences in demographics by infection group. Children infected with Zika virus had a range of neurological symptoms, some of which persisted for 6 to 12 months; however, no consistent pattern of symptoms was observed. At baseline a small percentage of children infected with Zika virus had an abnormal finger-to-nose test (13%), cold touch response (13%), and vibration response (15%) versus 0% in the uninfected group. Neurocognitive deficits and behavioral problems were common in both groups, with no significant differences between the groups. Children infected with Zika virus had lower cognitive efficiency scores at the 6-month visit. Anxiety and depression were infrequent in both groups. Conclusions. Larger studies are needed to definitively investigate the relationship between Zika virus infection and neurological symptoms and neurocognitive problems, with adjustment for factors affecting cognition and behavior, including mood and sleep disorders, home learning environment, history of neuroinvasive infections, and detailed family history of neuropsychological problems.

2 July 2025 in Kidney International Reports
Verified
Journal Article
Open access
JLJill F. Lebov
Jill F. Lebov
DBDaniel R. Brooks
Daniel R. Brooks
AAAnna Aceituno
Anna Aceituno
HAHildaura Acosta
Hildaura Acosta
JVJuan Amador Velázquez
Juan Amador Velázquez
SWSushrut S. Waikar
Sushrut S. Waikar
There has been an alarming increase in the incidence of a chronic kidney disease (CKD) of unknown etiology primarily affecting young individuals engaged in agricultural activities in Mesoamerica and South Asia. Despite extensive research over the past 2 decades, causes remain unclear. The disease is characterized by progressive loss of kidney function with the absence of heavy proteinuria and hematuria. The International Prospective Study of CKD of Unknown Etiology in Agricultural Communities (CURE study) aims to do the following: (i) identify factors associated with kidney function decline among individuals with or at risk for CKD of uncertain etiology (CKDu); (ii) better characterize the clinical phenotypes of individuals with CKDu and differentiate them from other forms of CKD; (iii) employ advanced laboratory and data analysis methods to conduct discovery science related to risk factors, biomarkers, and causal mechanisms; and (iv) establish a biorepository for future research. The CURE study is a prospective cohort study of up to 3600 participants from 7 sites in Central America and India aged 18 to 45 years with estimated glomerular filtration rate (eGFR) ≥ 20 ml/min per 1.73 m2, no evidence of diabetes, and no other known causes of CKD. Biological samples and questionnaire data are collected from participants during 4 visits at 8-month intervals. Blood, urine, and hair will be analyzed for kidney function biomarkers, trace elements, pesticides and other contaminants, untargeted metabolomics, and genetic assays. Environmental samples, collected from a subset of study participants, will be analyzed for trace elements, agrochemicals, and burning exposures. This study will provide novel information about CKDu etiology and clinical phenotypes across distinct geographies.